PGEN icon

Precigen

4.05 USD
+0.04
1%
At close Updated Oct 30, 4:00 PM EDT
Pre-market
After hours
4.00
--0.05
1.23%
1 day
1%
5 days
-6.47%
1 month
23.1%
3 months
134.1%
6 months
159.62%
Year to date
275%
1 year
391.74%
5 years
-5.59%
10 years
-87.84%
 

About: Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Employees: 25

0
Funds holding %
of 7,502 funds
0
Analysts bullish %
of 2 analysts
Positive news %
of articles
Price charts implemented using Lightweight Charts™